Viewing Study NCT00055367


Ignite Creation Date: 2025-12-25 @ 12:54 AM
Ignite Modification Date: 2026-05-17 @ 11:23 PM
Study NCT ID: NCT00055367
Status: COMPLETED
Last Update Posted: 2016-06-16
First Post: 2003-02-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability and Effectiveness of Natalizumab in Adolescents With Active Crohn's Disease
Sponsor: Biogen
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Crohn's Disease View
Keywords: